Literature DB >> 25759555

Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.

Meghan R Flanagan1, Arjun Jayaraj1, Wei Xiong1, Matthew M Yeh1, Wendy H Raskind1, Venu G Pillarisetty1.   

Abstract

Intraductal papillary mucinous neoplasm (IPMN) is a mucin-producing epithelial neoplasm that carries a risk of progression to invasive pancreatic ductal adenocarcinoma. Lynch syndrome is an autosomal dominant condition caused by germline mutations in mismatch repair genes such as MSH2 that lead to microsatellite instability and increased risk of tumor formation. Although families with Lynch syndrome have an increased risk of pancreatic cancer, a clear connection between Lynch syndrome and IPMN has not been drawn. We present a report of a 58 year-old Caucasian woman with multiple cancers and a germline mutation of MSH2 consistent with Lynch syndrome. A screening abdominal computed tomography scan revealed a dilated main pancreatic duct and cystic ductular structure in the uncinate process that were consistent with IPMN of the main pancreatic duct on excision. Immunohistochemistry and polymerase chain reaction of the patient's pancreas specimen did not reveal microsatellite instability or mismatch repair gene loss of expression or function. Our findings may be explained by the fact that loss of mismatch repair function and microsatellite instability is a late event in neoplastic transformation. Given the relative rarity of main duct IPMN, its appearance in the setting of somatic MSH2 mutation suggests that IPMN may fit into the constellation of Lynch syndrome related malignancies.

Entities:  

Keywords:  Hereditary nonpolyposis colorectal cancer; Intraductal papillary mucinous neoplasm; Lynch syndrome; MSH2; Microsatellite instability; Pancreatic cancer

Mesh:

Substances:

Year:  2015        PMID: 25759555      PMCID: PMC4351237          DOI: 10.3748/wjg.v21.i9.2820

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6.

Authors:  S Acharya; T Wilson; S Gradia; M F Kane; S Guerrette; G T Marsischky; R Kolodner; R Fishel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

2.  Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients.

Authors:  Chanjuan Shi; Alison P Klein; Michael Goggins; Anirban Maitra; Marcia Canto; Syed Ali; Richard Schulick; Emily Palmisano; Ralph H Hruban
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

3.  Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Terumi Kamisawa; Yuyang Tu; Naoto Egawa; Hitoshi Nakajima; Kouji Tsuruta; Atsutake Okamoto
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

4.  Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.

Authors:  Marietta E Kovacs; Janos Papp; Zoltan Szentirmay; Szabolcs Otto; Edith Olah
Journal:  Hum Mutat       Date:  2009-02       Impact factor: 4.878

5.  Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis.

Authors:  F Maire; P Hammel; B Terris; S Olschwang; D O'Toole; A Sauvanet; L Palazzo; P Ponsot; B Laplane; P Lévy; P Ruszniewski
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

6.  Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome.

Authors:  Jennifer A Sparr; Prathap Bandipalliam; Mark S Redston; Sapna Syngal
Journal:  Am J Surg Pathol       Date:  2009-02       Impact factor: 6.394

7.  The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.

Authors:  J W Poley; I Kluijt; D J Gouma; F Harinck; A Wagner; C Aalfs; C H J van Eijck; A Cats; E J Kuipers; Y Nio; P Fockens; M J Bruno
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

8.  High expression of intestinal-type mucin (MUC2) in intraductal papillary mucinous neoplasms coexisting with extrapancreatic gastrointestinal cancers.

Authors:  Sun-Young Lee; Dong Wook Choi; Kee-Taek Jang; Kyu Taek Lee; Seong Ho Choi; Jin Seok Heo; Jong Kyun Lee; Seung Woon Paik; Jong Chul Rhee
Journal:  Pancreas       Date:  2006-03       Impact factor: 3.327

9.  Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.

Authors:  L A Aaltonen; P Peltomäki; J P Mecklin; H Järvinen; J R Jass; J S Green; H T Lynch; P Watson; G Tallqvist; M Juhola
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  6 in total

1.  Pancreatic non-functioning neuroendocrine tumor: a new entity genetically related to Lynch syndrome.

Authors:  Anna Serracant Barrera; Sheila Serra Pla; Carmen María Blázquez Maña; Rubén Carrera Salas; Neus García Monforte; Natalia Bejarano González; Andreu Romaguera Monzonis; Francisco Javier Andreu Navarro; Maria Rosa Bella Cueto; Francisco G Borobia
Journal:  J Gastrointest Oncol       Date:  2017-10

Review 2.  Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer.

Authors:  Michele Ghidini; Andrea Lampis; Milko B Mirchev; Ali Fuat Okuducu; Margherita Ratti; Nicola Valeri; Jens C Hahne
Journal:  Genes (Basel)       Date:  2020-12-29       Impact factor: 4.096

Review 3.  Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors.

Authors:  Julie Leclerc; Catherine Vermaut; Marie-Pierre Buisine
Journal:  Cancers (Basel)       Date:  2021-01-26       Impact factor: 6.639

Review 4.  Intraductal Papillary Mucinous Neoplasms in Hereditary Cancer Syndromes.

Authors:  Devarshi R Ardeshna; Shiva Rangwani; Troy Cao; Timothy M Pawlik; Peter P Stanich; Somashekar G Krishna
Journal:  Biomedicines       Date:  2022-06-22

5.  MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors.

Authors:  Rui Gradiz; Henriqueta C Silva; Lina Carvalho; Maria Filomena Botelho; Anabela Mota-Pinto
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

Review 6.  Pancreatic Cancer in Lynch Syndrome Patients.

Authors:  Luis Bujanda; Marta Herreros-Villanueva
Journal:  J Cancer       Date:  2017-10-11       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.